FDA recommendations on BE trials during the pandemic [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-04-29 01:01 (1452 d 11:14 ago) – Posting: # 21358
Views: 2,921

Dear all,

The FDA has published high-level recommendations on bioequivalence studies for submission in ANDAs during the COVID-19 pandemic. Basically: it may be a mess outside (no kidding !), prioritise subjects' safety, use controlled correspondence.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,658 registered users;
105 visitors (0 registered, 105 guests [including 2 identified bots]).
Forum time: 12:16 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5